The American Osteopathic Association supports the reclassification of cannabis as a Schedule II Drug to facilitate advancement in clinical, public health, patient safety and health policy research, according to a resolution approved by the AOA House of Delegates.
Massachusetts law requires that all recreational marijuana products bear a seal showing they have been tested by a Commission-licensed independent laboratory for contaminants and potency levels.
Mounting evidence suggests that the inflammatory processes in the brain contribute to the pathologies of Parkinson's, Alzheimer's and HIV-Associated Neurocognitive Disorders.
Review claims that most people and many scientists are not aware of the potential uses for cannabinoids in treating cardiac hypertrophy and other heart diseases.
Whether it is introduced at the cultivator, processor or manufacturer level, ETCH biotrace links a unique molecular tag to the cannabis plant that will survive conversion or extraction.
CBD delivered from Lexaria’s TurboCBDTM capsules was absorbed much more effectively than from the positive control, delivering 317% more CBD to blood at the 30-minute mark of the study.
A unique cannabis strain that has the capacity to inhibit dendritic-dependent T-cells proliferation has been identified by researchers in Israel.
Achieving ISO/IEC 17025 accreditation is the pinnacle in third-party laboratory accreditation.
The grant will fund a series of preclinical studies to determine whether THC consumption during adolescence causes persistent neurological changes.